Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models (2022)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PARISE FILHO, ROBERTO - FCF ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; CARLOS, JORGE ANTONIO ELIAS GODOY - ICB
- Unidades: ICB; FCF
- DOI: 10.1016/j.htct.2022.09.265
- Assunto: ANTINEOPLÁSICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 44, Supl. 2, p. s157-s158, 2022
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO)
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.265. Acesso em: 31 mar. 2026. , 2022 -
APA
Carlos, J. A. E. G., Almeida, L. C., Lima, K., Tavares, M. T., Costa-Lotufo, L. V., Parise Filho, R., & Machado Neto, J. A. (2022). Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.265 -
NLM
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265 -
Vancouver
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265 - A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- Compostos híbridos e usos dos referidos compostos
- Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia
- Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Dona Flor and her two husbands: discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
- Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies
- AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy
- The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
- Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
